Denis Chem Lab (BOM:537536) Risk Assessment

View and export this data going back to 2014. Start your Free Trial

What is Denis Chem Lab Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Denis Chem Lab is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Denis Chem Lab's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Denis Chem Lab's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Denis Chem Lab's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Denis Chem Lab's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Denis Chem Lab's Risk Assessment falls into.

Denis Chem Lab (BOM:537536) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Denis Chem Lab Risk Assessment Related Terms

Thank you for viewing the detailed overview of Denis Chem Lab's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Denis Chem Lab (BOM:537536) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Denis Chem Lab Ltd (BOM:537536) » Definitions » Risk Assessment

Traded in Other Exchanges

N/A

Address

Satellite Road, 401 Abhishree Complex, Opposite OM Tower, Beside Bidiwala Park, Ahmedabad, GJ, IND, 380015

Website

http://www.denischemlab.com

Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.

Denis Chem Lab (BOM:537536) Headlines

No Headlines